Gary Holland to Disease Progression
This is a "connection" page, showing publications Gary Holland has written about Disease Progression.
Connection Strength
0.183
-
Visual acuity outcomes in cytomegalovirus retinitis: early versus late diagnosis. Br J Ophthalmol. 2018 12; 102(12):1607-1610.
Score: 0.034
-
Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy. Am J Ophthalmol. 2017 Feb; 174:23-32.
Score: 0.030
-
Cytomegalovirus retinitis: are intraocular devices the answer? Br J Ophthalmol. 1995 Dec; 79(12):1066-7.
Score: 0.028
-
Dose-related difference in progression rates of cytomegalovirus retinopathy during foscarnet maintenance therapy. AIDS Clinical Trials Group Protocol 915 Team. Am J Ophthalmol. 1995 May; 119(5):576-86.
Score: 0.027
-
Standardized visual field assessment for patients with birdshot chorioretinopathy. Ocul Immunol Inflamm. 2006 Dec; 14(6):325-32.
Score: 0.015
-
Clinician versus reading center assessment of cytomegalovirus retinitis lesion size. Ophthalmology. 2005 Apr; 112(4):559-66.
Score: 0.013
-
Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis. 2001 May 01; 183(9):1399-404.
Score: 0.010
-
Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group. Arch Ophthalmol. 2000 Sep; 118(9):1196-204.
Score: 0.010
-
Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 01; 17(4):339-44.
Score: 0.008
-
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med. 1997 Feb 15; 126(4):257-63.
Score: 0.008